0001493152-23-045171.txt : 20231215
0001493152-23-045171.hdr.sgml : 20231215
20231215214625
ACCESSION NUMBER: 0001493152-23-045171
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231215
FILED AS OF DATE: 20231215
DATE AS OF CHANGE: 20231215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kucinski Keith A
CENTRAL INDEX KEY: 0001763405
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38022
FILM NUMBER: 231492092
MAIL ADDRESS:
STREET 1: C/O MATINAS BIOPHARMA HOLDINGS INC.
STREET 2: 1545 RT. 206 SOUTH, SUITE 302
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Matinas BioPharma Holdings, Inc.
CENTRAL INDEX KEY: 0001582554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463011414
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1545 ROUTE 206 SOUTH
STREET 2: SUITE 302
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: 908-484-8805
MAIL ADDRESS:
STREET 1: 1545 ROUTE 206 SOUTH
STREET 2: SUITE 302
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
ownership.xml
X0508
4
2023-12-15
0
0001582554
Matinas BioPharma Holdings, Inc.
MTNB
0001763405
Kucinski Keith A
C/O MATINAS BIOPHARMA HOLDINGS, INC.
1545 ROUTE 206 SOUTH SUITE 302
BEDMINSTER
NJ
07921
0
1
0
0
Chief Financial Officer
0
Stock Option (right to Buy)
0.247
2023-12-15
4
A
0
1000000
0
A
2033-12-15
Common Stock
1000000
1000000
D
The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 15, 2024 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2024.
/s/ Keith A. Kucinski
2023-12-15